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Introduction. Given the large number of patients discussed in our Center (Centro oncológico de Galicia) with radiotherapy in
abdominal–pelvic locations. We decided to study the use of a natural product like cranberry, to prevent one of the side effects
more pronounced in this type of treatment: The urinary toxicity.
Objectives. Assess the effectiveness of cranberry in preventing urinary toxicity in patients undergoing radiotherapy in
abdominal–pelvic areas, at the Centro oncológico de Galicia.
Methods. The ﬁrst task was to collect the data and select patients for various diseases, undergoing abdomino-pelvic irradiation
(prostate, rectum, cervix, and bladder). After being seen by the radiation oncologist as new patients, they come to our ofﬁce
nursing, where we provide the product and we make appropriate recommendations on the use of the same. Throughout the
treatment, perform weekly checks for assessing symptoms such as burning, itching, urinary urgency, urinary incontinence,
urinary difﬁculty, hematuria, dysuria. . .. Performing urinalysis treatment over if it’s necessary.
Conclusions. Demonstrated the efﬁciency in preventing urinary symptoms of toxicity and decreasing the intensity of these
symptoms when they occur. Cranberry contributes to improving the quality of life of patients during treatment with radiotherapy.
http://dx.doi.org/10.1016/j.rpor.2013.03.741
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Objective. To evaluate the inﬂuence of radiation dermatitis in the quality of life of women with breast cancer treated with radiation
therapy after conservative surgery.
Material and methods. Observational, prospective longitudinal done at the Department of Radiation Oncology – CHGUV-ERESA
between December and June 2012 in 35 patients requiring breast irradiation. Inclusion criteria: Conservative surgery, absence of
cognitive impairment and Spanish-speaking. The assessment of quality of life was performed using two validated questionnaires
for Spanish, DLQI1 and Skindex-29.2,3 Three surveys were conducted DLQI (the ﬁrst and last week of treatment and one month
after the end). The Skindex-29 was performed at the end of treatment and at three scales are rated: functional, emotional and
symptomatic. All patients followed the protocol radiodermatitis prevention of service.
Results. In the valuation of impaired quality of life on the end of treatment shows that in DLQI: only 3 participants had scores of
10 or higher on a total score of 30, this represents a low inﬂuence. When spend a month of the end of treatment, further reduces
this inﬂuence. The items on pain, burning and itching were the highest. In Skindex-29 only two women had scores of 35 and 38
out of 100 representing a half affectation. In the remaining women, affectation was low or very low.
Conclusions. Contrary to what is concluded in recent publications,4,5 this study shows a low alteration of the quality of life
of women with breast irradiation. These results are highly dependent on Radiation Oncology service where treatment takes
place as they depend protocols on the acceptance of treatment and the protocols for prevention and management of radiation
dermatitis that are used in each service.
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